NEW MILTON, UK--(BUSINESS WIRE)--Genetix Group plc (AIM: GTX), the cancer diagnostic and biopharmaceutical technologies group, today announces that it has been awarded a contract to develop and implement a nationwide network of Automated Cytogenetic Analysis Systems by NHS National Services Scotland (NHSScotland).
